Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.

Cabel CR, Guzman BA, Alizadeh E, et al. "Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors." Front Cell Dev Biol. 2025;13:1538934.